AGTC News and Press, Applied Genetic Technologies Corporation From 09/28/21

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare inherited ret...

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare inherited retinal disea...

The following slide deck was published by Applied Genetic Technologies Corporation in conjunction with their 2022 Q4 earnings call. For further details see: Applied Genetic Technologies Corporation 2022 Q4 - Results - Earnings Call Presentation

Applied Genetic Technologies Corporation (AGTC) Q4 2021 Earnings Conference Call September 24, 2021 16:30 ET Company Participants Sue Washer - Chief Executive Officer Jon Lieber - Chief Financial Officer Stephen Potter - Chief Business Officer Matt Feinsod - Executive Vice President, Global C...

Applied Genetic (NASDAQ:AGTC): Q4 GAAP EPS of -$0.28 beats by $0.12. Revenue of $0.5M Press Release Financial Guidance:  As of June 30, 2021, the Company's cash, cash equivalents and investments totaled $107.1M. Net loss was $12.1M. Shares +3.2% after hours For furt...

-Data from ongoing clinical trials in XLRP and ACHM shows evidence of clinical activity and tolerability; multiple data readouts expected in 2021 and 2022- -Pre-Clinical programs moving to IND enabling animal studies- -Company adds experienced industry veterans to board and manage...

AEHR, AGTC, AIR, DADA, COST, MTN, NKE, PRGS, TCOM For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Thursday's close

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare inherited retinal disea...

AGTC, FCEL For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Tuesday's open

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare inherited ret...